Everest Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Everest Management's BMY Position: Q3 2026 in Review
Everest Management opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,549 shares worth $221K. The stake represents 0.07% of the portfolio and ranks #105 among its holdings. This is a return to the name: Everest Management previously reported a position in BMY as recently as Q1 2026.
Everest Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Everest Management held 3,549 shares of Bristol-Myers Squibb worth $221K as of Q3 2026.
- Bristol-Myers Squibb was a new Everest Management position in Q3 2026.
- Bristol-Myers Squibb made up 0.07% of Everest Management's portfolio in Q3 2026, its #105 holding.
- Everest Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Everest Management's 13F filing for Q3 2026, filed 10 Nov 2026.